Topical indomethacin for vernal keratoconjunctivitis.
Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.
Gupta
S
S
Department of Ophthalmology-II Medical College, Rohtak, India.
Khurana
A K
AK
Ahluwalia
B K
BK
Gupta
N C
NC
D000287:Administration, Topical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003233:Conjunctivitis, Allergic / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005500:Follow-Up Studies; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D011379:Prognosis
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009883:Ophthalmic Solutions; D007213:Indomethacin